The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000212.3(ITGB3):c.58C>T (p.Leu20=)

CA8622836

323863 (ClinVar)

Gene: ITGB3
Condition: Glanzmann thrombasthenia
Inheritance Mode: Autosomal recessive inheritance
UUID: e677c970-cc94-46af-898a-0bb16dfa91cd

HGVS expressions

NM_000212.3:c.58C>T
NM_000212.3(ITGB3):c.58C>T (p.Leu20=)
NC_000017.11:g.47253919C>T
CM000679.2:g.47253919C>T
NC_000017.10:g.45331285C>T
CM000679.1:g.45331285C>T
NC_000017.9:g.42686284C>T
NG_008332.2:g.5078C>T
ENST00000559488.7:c.58C>T
ENST00000559488.5:c.58C>T
ENST00000560629.1:n.23C>T
ENST00000571680.1:c.58C>T
NM_000212.2:c.58C>T

Benign

Met criteria codes 2
BA1 BP4
Not Met criteria codes 1
BP7

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
After a comprehensive literature search of the synonymous variant NM_000212.3(ITGB3):c.58C>T (p.Leu20=), no individuals with Glanzmann thrombasthenia were reported with the variant. This variant was observed by Ilumina as part of a predisposition screen in an ostensibly healthy population. Moreover, the variant has a minor allele frequency of 0.01438 (146/10154 alleles) in gnomAD, found in the African/African American population, which is considerably higher than the expected frequency of the disease (BA1). In silico predictor spliceAI revealed that the synonymous mutation is not expected to impact splicing. However, BP7 was not applied as the nucleotide position is conserved. In summary, this variant meets the criteria to be classified as Benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1 and BP4 (PD VCEP specifications version 2.1).
Met criteria codes
BA1
The highest population minor allele frequency in gnomAD v2.1.1 is 0.01438 (146/10154 alleles) in the African/African American population, which is higher than the ClinGen PD VCEP threshold (>0.0024), and therefore meets this criterion (BA1).
BP4
The c.58C>T (p.Leu20=) variant is a synonymous variant that is not predicted by SpliceAI to impact splicing (BP4).
Not Met criteria codes
BP7
The c.58C>T (p.Leu20=) variant is a synonymous variant that is not predicted by SpliceAI to impact splicing. However, BP7 was not applied because the nucleotide is highly conserved, as shown by phyloP score of 2.816.
Approved on: 2023-03-21
Published on: 2023-03-21
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.